Cargando…
Metabolism and Interspecies Variation of IMMH-010, a Programmed Cell Death Ligand 1 Inhibitor Prodrug
IMMH-010 is an ester prodrug of YPD-29B, a potent programmed cell death ligand 1 (PD-L1) inhibitor. The metabolism of IMMH-010 was investigated and compared in various species. Four metabolites of IMMH-010 were identified, and the major metabolite was the parent compound, YPD-29B, which was mainly c...
Autores principales: | Wang, Yuchen, Liu, Xiao, Zou, Xiaowen, Wang, Shuting, Luo, Lijun, Liu, Yuke, Dong, Kai, Yao, Xiaoqing, Li, Yan, Chen, Xiaoguang, Sheng, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143347/ https://www.ncbi.nlm.nih.gov/pubmed/33919384 http://dx.doi.org/10.3390/pharmaceutics13050598 |
Ejemplares similares
-
Simultaneous Determination of a Novel PD-L1 Inhibitor, IMMH-010, and Its Active Metabolite, YPD-29B, in Rat Biological Matrices by Polarity-Switching Liquid Chromatography-Tandem Mass Spectrometry: Application to ADME Studies
por: Jiang, Jianwei, et al.
Publicado: (2021) -
A novel S1P1 modulator IMMH002 ameliorates psoriasis in multiple animal models
por: Jin, Jing, et al.
Publicado: (2020) -
Sphingosine-1-Phosphate Receptor Subtype 1 (S1P1) Modulator IMMH001 Regulates Adjuvant- and Collagen-Induced Arthritis
por: Jin, Jing, et al.
Publicado: (2019) -
Immucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral Leishmaniasis
por: Freitas, Elisangela Oliveira, et al.
Publicado: (2015) -
The nucleoside antiviral prodrug remdesivir in treating COVID-19 and beyond with interspecies significance
por: Yan, Daisy, et al.
Publicado: (2021)